EricStephenWinerMD

PubMed

• Lower-intensity CPX-351 plus venetoclax induction for adults with newly diagnosed AML unfit for intensive chemotherapy.
  Geoffrey L Uy, Vinod Pullarkat, Praneeth Baratam, Robert K Stuart, Roland B Walter
  Blood Advances. 2024-12-24
• Venetoclax plus low intensity chemotherapy for adults with acute lymphoblastic leukemia.
  Marlise R Luskin, Shai Shimony, Julia H Keating, Eric S Winer, Jacqueline S Garcia
  Blood Advances. 2024-11-15
• AML in the Elderly - When less may be more.
  Eric S Winer, Richard M Stone
  Current Oncology Reports. 2024-11-01

Abstracts/Posters

• First Line Chemo-Free Therapy with the BRAF Inhibitor Vemurafenib Combined with Obinutuzumab Is Effective in Patients with Hcl
  Eric S. Winer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• A Multicenter Phase I Study Combining Venetoclax with Mini-Hyper-CVD in Older Adults with Untreated and Relapsed/Refractory Acute Lymphoblastic Leukemia
  Eric S. Winer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Sleep Disturbance Among Patients with Myelodysplastic Syndromes and Acute Leukemia
  Eric S. Winer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Clinical and Immunologic Activity of Ipilimumab Following Decitabine Priming in Post-Allogeneic Transplant and Transplant-Na¥ve Patients with Relapsed or Refractory My...
  Eric S. Winer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical, Clinical, and Correlative Studies
  Eric S. Winer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Join now to see all